Amgen’s Subpoena Of Reporter In Aranesp Securities Case Quashed By Court

(September 2, 2015, 12:03 PM EDT) -- WASHINGTON, D.C. — A District of Columbia federal judge on Aug. 21 granted a reporter’s motion to quash a subpoena seeking to depose him in a securities class action, finding that the issuing firm failed to overcome the reporter’s privilege under the First Amendment to the U.S. Constitution (Paul B. Goldberg v. Amgen Inc., No. 1:15-mc-00825, D. D.C.; 2015 U.S. Dist. LEXIS 110726).

(Memorandum opinion and order available. Document #68-150910-006Z.)

Shareholder Action

Biotechnology firm Amgen Inc. is presently involved in a shareholder class action in the...
To view the full article, register now.